# Triple-Hormone-Receptor Agonist Retatrutide for Obesity.

> PubMed lists PMID 37888926 in The New England journal of medicine as Letter, Comment, with publication-date metadata of 2023-10-26 (day precision). PeptideScanner associated the retained record with the identity slug retatrutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-37888926-retatrutide:v1`
- Evidence domain: Literature metadata
- Date in source: 2025-07-03
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-13
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-37888926-retatrutide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-37888926-retatrutide-v1.json
- Content SHA-256: `4ef8ed6122263e031614376dbb5e6cd555546977bb87367662f551503d0b8314`

## Claims and source pins

### Headline

Triple-Hormone-Receptor Agonist Retatrutide for Obesity. ([`pubmed-observation-pmid-37888926-2025-07-03-b72d53d465bd`](#source-pubmed-observation-pmid-37888926-2025-07-03-b72d53d465bd))

### Summary

PubMed lists PMID 37888926 in The New England journal of medicine as Letter, Comment, with publication-date metadata of 2023-10-26 (day precision). PeptideScanner associated the retained record with the identity slug retatrutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-37888926-2025-07-03-b72d53d465bd`](#source-pubmed-observation-pmid-37888926-2025-07-03-b72d53d465bd))

### Paragraph 1

PubMed lists PMID 37888926 in The New England journal of medicine as Letter, Comment, with publication-date metadata of 2023-10-26 (day precision). PeptideScanner associated the retained record with the identity slug retatrutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-37888926-2025-07-03-b72d53d465bd`](#source-pubmed-observation-pmid-37888926-2025-07-03-b72d53d465bd))

### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-37888926-2025-07-03-b72d53d465bd`](#source-pubmed-observation-pmid-37888926-2025-07-03-b72d53d465bd))

## Sources

<a id="source-pubmed-observation-pmid-37888926-2025-07-03-b72d53d465bd"></a>
- **Triple-Hormone-Receptor Agonist Retatrutide for Obesity. · retained source version 1:2025-07-03:current:b72d53d465bdbd32536001339546ddb5df25fdfa26c478f1010e16cab430a9d8** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/37888926/) (`pubmed-observation-pmid-37888926-2025-07-03-b72d53d465bd`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "Triple-Hormone-Receptor Agonist Retatrutide for Obesity." Version 1, published 2026-08-13. https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-37888926-retatrutide-v1.json SHA-256: 4ef8ed6122263e031614376dbb5e6cd555546977bb87367662f551503d0b8314.